Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543332 | NSE Symbol : EPIGRAL | ISIN : INE071N01016 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
18-Jan-2025	27-Jan-2025	Quarterly Results	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2025 inter alia to consider and approve Un-Audited Financial Results for the Third Quarter and Nine Months ended on 31st December 2024 and to declare Interim Dividend on the equity shares of the Company for the Financial Year 2024-25. Outcome of Board Meeting held on Monday, 27th January, 2025 containing submission of Un-Audited Financial Results (Standalone & Consolidated) for the Third Quarter and Nine Months ended on 31st December, 2024 and Declaration of interim dividend of Rs. 2.50 (25%) per Equity Share of face value of Rs. 10/- each for the Financial Year 2024-25. (As Per BSE Announcement Dated on 27/01/2025)
29-Oct-2024	09-Nov-2024	Quarterly Results	Quarterly Results Outcome of Board Meeting held on Saturday, 9th November, 2024 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and Half Year ended on 30th September, 2024. UFR - 30.09.2024 Expansion of production capacity of CPVC and Epichlorohydrin at Dahej, Gujarat. (As Per BSE Announcement Dated on 09.11.2024)
09-Aug-2024	14-Aug-2024	Raising funds through Debt Instr.	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve inter alia proposal for raising of funds through issuance of instruments or security including equity shares or any other eligible securities by way of one or more public and/or private offerings including on a preferential allotment basis and/or a qualified institutions placement subject to such regulatory statutory approvals as may be required including approval of the shareholders of the Company. Raising of funds through issuance of instruments or security including equity shares or any other eligible securities by way of one or more public and/or private offerings including on a preferential allotment basis and/or a qualified institutions placement for an amount not exceeding Rs.500 Crores (Rupees Five Hundred Crores Only). (As Per BSE Announcement Dated on 14.08.2024)
16-Jul-2024	24-Jul-2024	Quarterly Results	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2024 inter alia to consider and approve Un-audited Financial Results for Quarter ended 30th June 2024. Epigral Limited submits the unaudited financial results for the quarter ended on 30.06.2024. Outcome of Board Meeting held on Wednesday, 24th July, 2024 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the First Quarter ended on 30th June, 2024 Epigral Limited (formerly known as Meghmani Finechem Limited) copy of Newspaper Publication pertaining to Un-audited Financial Results for quarter ended 30.06.2024. (As per BSE Announcement Dated on 24/07/2024)
09-Apr-2024	22-Apr-2024	Quarterly Results	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2024 inter alia to consider and approve Audited Financial Results for the quarter and year ended on 31.03.2024 and recommendation of Final Dividend if any. Outcome of Board Meeting held on Monday, 22nd April, 2024 Audited Financial Results for the quarter and year ended on 31.03.2024. (As Per BSE Announcement Dated on 22.04.2024)
02-Jan-2024	24-Jan-2024	Quarterly Results	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 inter alia to consider and approve Un-Audited Financial Results of the Company for the Third Quarter and Nine Months ended on 31st December 2023. Epigral Limited (formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the Third Quarter and Nine months ended on 31st December, 2023. Epigral Limited (formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the Third Quarter and Nine months ended on 31st December, 2023. (As Per BSE Announcement Dated on 24/01/2024)
11-Oct-2023	06-Nov-2023	Quarterly Results	Epigral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2023 inter alia to consider and approve Un-Audited Financial Results for second quarter and half year ended 30th September 2023. Outcome of Board Meeting held on 06th November, 2023 and submission of Un-Audited Financial Results (Standalone & Consolidated) for Second Quarter and Half Year ended on 30th September, 2023. Outcome of the Board Meeting held on Monday, 6th November, 2023 and submission of Un-Audited Financial Results (Standalone & Consolidated) for second quarter and half year ended 30th September, 2023. (As Per BSE Announcement Dated on 06/11/2023) Epigral Limited (formerly known as Meghmani Finechem Limited) submits newspaper publication of Un-audited Financial Results for second quarter and half year ended 30.09.2023 published in Financial Express (English & Gujarati) on 07.11.2023. (As Per BSE Announcement Dated on 07/11/2023)
28-Jul-2023	05-Aug-2023	Quarterly Results	Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended on 30.06.2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) submits the Unaudited Financial Results for the quarter ended on 30th June, 2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) submits the Outcome of Board Meeting held on 05.08.2023. Epigral Limited (Formerly known as Meghmani Finechem Limited) intimate for Change in Designation of the Directors. (As Per BSE Announcement Dated on 05.08.2023)
13-Jun-2023	13-Jun-2023	Postal Ballot	Meghmani Finechem Limited informs that the Board of Directors of the Company at its meeting held today i.e. 13th June, 2023 considered the following matters: 1. Subject to the approval of the Members of the Company through Postal Ballot and/or other Regulatory approvals including Stock Exchanges, as may be required, to: a. Change the Name of the Company to such Name as may be approved by the Ministry of Corporate Affairs. b. Reclassification of Status of Promoter Group Shareholders to Public Shareholders as per Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Attached extract from the minutes of the meeting of the Board of Directors. Meghmani Finechem Limited informs that the Office of the Registrar of Companies Central Registration Centre Ministry of Corporate Affairs Manesar has granted their No Objection in the availability of the changed name EPIGRAL LIMITED from the existing name MEGHMANI FINECHEM LIMITED. Meghmani Finechem Limited informs that the Office of the Registrar of Companies Central Registration Centre Ministry of Corporate Affairs Manesar has granted their No Objection in the availability of the changed name EPIGRAL LIMITED from the existing name MEGHMANI FINECHEM LIMITED. (As Per BSE Announcement Dated on 19.06.2023)
12-Apr-2023	25-Apr-2023	Accounts	Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2023 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Year ended on 31st March 2023 and recommendation of Final Dividend if any on the Equity Shares. Meghmani Finechem Limited informs that the Board of Directors at its meeting held today i.e. Tuesday, 25th April, 2023 has inter-alia transacted the following business: 1. Approved Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Year ended on 31st March, 2023 and took on record Auditor's Report thereon issued by Statutory Auditors of the Company. A copy of the approved Audited Financial Results along with Auditor's Report is enclosed. We hereby declare and confirm that the Statutory Auditors of the Company, M/s S R B C & CO LLP, Chartered Accountants, have issued an unmodified Audit Report on the Audited Financial Results of the Company for the financial year ended 31st March 2023. 2. Recommended final dividend of Rs. 2.50 (25%) per equity share on 4,15,50,158 Equity Shares of Rs. 10/- each for the financial year ended 31st March, 2023, subject to approval of the Shareholders of the Company at the forthcoming Annual General Meeting. Meghmani Finechem Limited submits herewith Audited (Standalone and Consolidated) Financial Results of the Company for the Quarter and Year ended on 31st March, 2023 and took on record Auditor's Report thereon issued by Statutory Auditors of the Company. (As Per BSE Announcement Dated on 25.04.2023)
11-Jan-2023	19-Jan-2023	Quarterly Results	Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/01/2023 inter alia to consider and approve Un-audited Financial Results of the Company for the Third Quarter ended on 31 December 2022 along with the Limited Review Reports of the Statutory Auditors thereon. The Board may also consider and recommend Interim Dividend if any on the Equity Shares of the Company for FY 2022-23 Meghmani Finechem Limited informs that the Board of Directors of Meghmani Finechem Limited at its meeting held on today i.e. on Thursday, January 19, 2023 has inter-alia considered and approved the following: (1) The un-audited (Standalone and Consolidated) financial results of the Company for the Third quarter and Nine months ended on December 31, 2022. A copy of the approved un-audited financial results along with limited review report of Statutory Auditor is enclosed. (2) The Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23. Meghmani Finechem Limited informs that the Board of Directors of the Company at its meeting held today i.e. on 19th January, 2023 has also declared Interim Dividend at Rs. 2.50/- (i.e. 25%) per Equity Share on 4,15,50,158 Equity Shares of Rs. 10/- each for the year FY 2022-23. (As Per BSE Announcement Dated on 19/01/2023)
08-Oct-2022	20-Oct-2022	Quarterly Results	Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2022 inter alia to consider and approve Meghmani Finechem Limited informs that the meeting of the Board of Directors of the Company will be held on Thursday 20th October 2022 at Meghmani House B/h Safal Profitaire Corporate Road Prahladnagar Ahmedabad - 380 015 to consider approve and take on record Un-audited Financial Results of the Company for the Second Quarter and Half Year ended on 30th September 2022 along with the Limited Review Reports of the Statutory Auditors thereon. Meghmani FInechem Limited informs that the Board of Directors of the Company at its meeting held on 20th October, 2022, have inter-alia, considered and approved Unaudited Financial Results (Consolidated & Standalone) of the Second Quarter/Half year ended on 30th September, 2022 prepared in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which were reviewed by Audit Committee and approved by Board of Directors at their meeting held today i.e. on 20th October, 2022 is forwarded herewith. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have carried out a limited review Report on Un-audited Financial Results (Consolidated & Standalone) of the Second Quarter/Half year ended 30th September, 2022 with unmodified opinion and the same is also forwarded herewith. Outcome of the Board Meeting held on Thursday, 20th October, 2022 and submission Financial Results (Consolidated & Standalone) of the Second Quarter/Half year ended on 30th September, 2022 (As Per BSE Announcement Dated on 20/10/2022)
07-Jul-2022	21-Jul-2022	Quarterly Results	Quarterly Results Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that the meeting of the Board of Directors of the Company will be held on Thursday, 21st July, 2022, at Meghmani House, B/h Safal Profitaire, Corporate Road, Prahladnagar, Ahmedabad - 380 015 to consider, approve and take on record Un-audited Financial Results of the Company for the First Quarter ended on 30 June, 2022 along with the Limited Review Reports of the Statutory Auditors thereon. Meghmani Finechem Limited submits herewith Financial Results (Consolidated & Standalone) of the First Quarter ended on 30th June, 2022. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have carried out a limited review Report on Un-audited Financial Results (Consolidated & Standalone) of the First Quarter ended 30th June, 2022 with unmodified opinion and the same is also forwarded herewith. (As Per BSE Announcement Dated 21.07.2022)
04-Apr-2022	25-Apr-2022	Accounts	Audited Results Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2022 ,inter alia, to consider and approve Standalone and Consolidated Audited Financial Results of the Company for the year ended on 31st March, 2022 along with other Statutory reports thereon. Outcome of Board Meeting held on 25th April,2022 Standalone and Consolidated Audited Financial Results for the Quarter/ Year ended 31st March, 2022. (As per BSE Announcement Dated on 25/4/2022)
04-Jan-2022	24-Jan-2022	Quarterly Results	Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform that the meeting of the Board of Directors of the Company will be held on Monday, 24th January, 2022, at Meghmani House, B/h Safal Profitaire, Corporate Road, Prahladnagar, Ahmedabad - 380 015, to consider, approve and take on record standalone and consolidated unaudited Financial Results of the Company for the Third Quarter ended on 31st December, 2021 along with the Limited Review Reports of the Statutory Auditors thereon. Further, as per the Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window Closure Period will end 48 hours after the results are made public on Monday, 24th January, 2022. Meghmani Finechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2022 ,inter alia, to consider and approve Revised Intimation for additional agenda to shift Registered Office of the Company to be considered at the Board Meeting of Meghmani Finechem Limited to be held on Monday, 24th January, 2022. (As Per BSE Announcement Dated on 17.01.2022) We wish to inform you that the Board of Directors of the Company at its meeting held on 24th January, 2022, has inter-alia, considered and approved : 1. Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Un Audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended on 31st December, 2021 reviewed by Audit Committee and approved by Board of Directors at their meeting held today i.e. on 24th January, 2022 is forwarded herewith. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have also carried out a limited review Report thereon. 2. The Shifting of the registered office of the Company from District Bharuch to District Ahmedabad, within the State of Gujarat subject to approval of shareholders. The Draft Notice of Postal Ballot along with the explanatory statement was also approved. We wish to inform you that the Board of Directors of the Company at its meeting held on 24th January, 2022, has inter-alia, considered and approved : Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Un Audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended on 31st December, 2021 reviewed by Audit Committee and approved by Board of Directors at their meeting held today i.e. on 24th January, 2022 is forwarded herewith. The Statutory Auditors M/s S R B C & CO LLP, Chartered Accountants have also carried out a limited review Report on Un-audited Financial Results (Consolidated & Standalone) of the Third Quarter & Nine Months ended 31st December, 2021 and the same is also forwarded herewith. (As per BSE Announcement Dated on 24/01/2022)

1 2

LOGIN HERE

Epigral Ltd

Board Meeting